Radiotherapy & Oncology
Volume 95, Issue 2 , Pages 191-197 , May 2010

Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers

  • Tomas Kron

      Affiliations

    • Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia
    • Applied Physics, RMIT University, Melbourne, Australia
    • Corresponding Author InformationCorresponding author. Address: Department of Physical Sciences, Peter MacCallum Cancer, St Andrews Place, Melbourne Victoria 3002, Australia.
  • ,
  • Jessica Thomas

      Affiliations

    • Radiation Oncology
  • ,
  • Chris Fox

      Affiliations

    • Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia
  • ,
  • Ann Thompson

      Affiliations

    • Radiation Therapy; and
  • ,
  • Rebecca Owen

      Affiliations

    • Radiation Therapy; and
  • ,
  • Alan Herschtal

      Affiliations

    • Biostatisitics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia
  • ,
  • Annette Haworth

      Affiliations

    • Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia
    • Applied Physics, RMIT University, Melbourne, Australia
  • ,
  • Keen-Hun Tai

      Affiliations

    • Radiation Oncology
    • Department of Pathology, University of Melbourne, Parkville, Australia
  • ,
  • Farshad Foroudi

      Affiliations

    • Radiation Oncology
    • Department of Pathology, University of Melbourne, Parkville, Australia

Received 1 June 2009 ,Revised 21 January 2010 ,Accepted 23 January 2010.

References 

  1. Zelefsky MJ, Yamada Y, Fuks Z, et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys. 2008;71:1028–1033
  2. Hanks GE, Hanlon AL, Epstein B, Horwitz EM. Dose response in prostate cancer with 8–12 years’ follow-up. Int J Radiat Oncol Biol Phys. 2002;54:427–435
  3. Al-Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:980–988
  4. Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys. 2005;62:406–417
  5. Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:89–105
  6. van Herk M. Different styles of image-guided radiotherapy. Semin Radiat Oncol. 2007;17:258–267
  7. Gauthier I, Carrier JF, Beliveau-Nadeau D, Fortin B, Taussky D. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. Int J Radiat Oncol Biol Phys. 2009;74:1128–1133
  8. ICRU. ICRU report 62: Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU report 50). ICRU reports, Bethesda: International Commission on Radiological Units and Measurements. 2000.
  9. Nederveen AJ, Van der Heide UA, Dehnad H, van Moorselaar RJ, Hofman P, Lagendijk JJ. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 2002;53:206–214
  10. Kitamura K, Shirato H, Seppenwoolde Y, et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys. 2002;53:1117–1123
  11. Shimizu S, Shirato H, Kitamura K, et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys. 2000;48:1591–1597
  12. Langen KM, Willoughby TR, Meeks SL, et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2008;71:1084–1090
  13. Kupelian P, Willoughby T, Mahadevan A, et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys. 2007;67:1088–1098
  14. Noel. Prediction of intrafraction prostate motion. 2009.
  15. Thompson A, Fox C, Foroudi F, et al. Planning and implementing an implanted fiducial programme for prostate cancer radiation therapy. J Med Imaging Radiat Oncol. 2008;52:419–424
  16. Fox C, Fisher R, Kron T, Foroudi F. Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system. J Med Imag Radiat Oncol. 2009;
  17. Everitt S, MacManus M, Kron T, Leong T. Geographic miss in radiation oncology: have we missed the boat? Opinion piece. J Med Imaging Radiat Oncol. 2009;
  18. van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys. 2002;52:1407–1422
  19. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121–1135
  20. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35:310–317
  21. Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008;72:996–1001
  22. Engels B, Soete G, Verellen D, Storme G. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers. Int J Radiat Oncol Biol Phys. 2009;74:388–391
  23. Noel C, Parikh PJ, Roy M, et al. Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. Int J Radiat Oncol Biol Phys. 2009;73:692–698
  24. Nederveen A, Lagendijk J, Hofman P. Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK). Int J Radiat Oncol Biol Phys. 2000;47:1435–1442
  25. Hoogeman MS, van Herk M, de Bois J, Lebesque JV. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol. 2005;74:177–185
  26. van Herten YR, Van de Kamer JB, van Wieringen N, Pieters BR, Bel A. Dosimetric evaluation of prostate rotations and their correction by couch rotations. Radiother Oncol. 2008;88:156–162
  27. Aubry JF, Beaulieu L, Girouard LM, et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys. 2004;60:30–39
  28. Owen, R, Foroudi, F, Cox, J, Kron, T, Duchesne, G. Inter-fraction prostate rotation determined from in-room computerised tomography (CT) images taken during radiotherapy verification. Med Dosim; submitted.
  29. Redpath AT, Wright P, Muren LP. The contribution of on-line correction for rotational organ motion in image-guided radiotherapy of the bladder and prostate. Acta Oncol. 2008;47:1367–1372
  30. Liang J, Wu Q, Yan D. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;
  31. Miles EF, Lee WR. Hypofractionation for prostate cancer: a critical review. Semin Radiat Oncol. 2008;18:41–47
  32. Ritter M, Forman J, Kupelian P, Lawton C, Petereit D. Hypofractionation for prostate cancer. Cancer J. 2009;15:1–6
  33. ICRU. ICRU report 50: Prescribing, recording, and reporting photon beam therapy. ICRU reports, Bethesda: International Commission on Radiological Units and Measurements. 1993.
  34. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14:52–64
  35. McKenzie AL, van Herk M, Mijnheer B. The width of margins in radiotherapy treatment plans. Phys Med Biol. 2000;45:3331–3342
  36. Herschtal A, Kron T, Fox C. Radiotherapy margin design with particular consideration of high curvature CTVs. Med Phys. 2009;36:684–697

PII: S0167-8140(10)00061-7

doi: 10.1016/j.radonc.2010.01.010

Radiotherapy & Oncology
Volume 95, Issue 2 , Pages 191-197 , May 2010